Floatz logo

Coagulation Factor Viia Variant

Factor VII Deficiency

Catalyst BiosciencesPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Factor VII Deficiency cohort.

Asset / SponsorPhaseRating
sr604
Shanghai RAAS Blood Products Co., Ltd.
Phase 1/2CCC
DPC-A69448
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 1CC

Same molecule, other indications

Coagulation Factor Viia Variant is also rated in:

hemophilia ADormant
B
Indicative ·
59 / 100
View asset →
hemophilia BDormant
CCC
Indicative ·
55 / 100
View asset →
Glanzmann thrombastheniaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →